PanTum® Detect

SAFE, ACCURATE AND CLINICALLY PROVEN GERMAN TECHNOLOGY

0123456789001234567890                     .01234567890                     %
Sensitivity*
*Sensitivity: True positives
0123456789001234567890                     %
Specificity*
* Specificity: True negatives
0123456789001234567890                     +
Publication
01234567890                     ,012345678900123456789001234567890                     +
Candidate Studies
012345678900123456789001234567890                     ,012345678900123456789001234567890                     +
Tests sold globally

PanTum® Detect is a multi-tumor screening blood test that “filters” asymptomatic healthy individuals by screening for the presence of silently growing benign, premalignant or malignant tumors.

The test has an IVD CE certified sensitivity of 97.5% and a specificity of 99%. It uses EDIM® (Epitope Detection in Monocytes) technology to detect multi-tumor enzyme biomarkers Apo10 and TKTL1 in immune cells (macrophages) which are detectable in all phases of tumor development.

This revolutionary, thoroughly researched and scientifically proven technology leverages our innate immune system thus making it possible to detect tumors in early stages.

The “Cancer-Scan” program combines pre-testing with PanTum® Detect and confirmatory cancer detection diagnostics (advanced imaging techniques and diagnostic pathology) for those who test positive with PanTum® Detect into an integrated multi-tumor screening concept for “timely” detection of tumors.

Technology behind PanTum® Detect Test

Leveraging the immune system to deliver high accuracy of PanTum® Detect test

The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.

https://www.medidect.com/wp-content/uploads/2023/04/EDIM1.png

Consumer Journey Powered by PanTum® Detect

Don’t wait for onset of symptoms, pre-book your test today. Book now

https://www.medidect.com/wp-content/uploads/2023/02/Consumer-Journey2.png

Consumer Journey Powered by PanTum® Detect

Don’t wait for onset of symptoms, pre-book your test today. Book now

https://www.medidect.com/wp-content/uploads/2023/02/Consumer-Journey2.png

OUR EXPERTSWe'll Ensure You Always Get the Best Results

https://www.medidect.com/wp-content/uploads/2022/10/Dr.-Sethi.png
"Pantum® Detect is a truly innovative and revolutionary test in the field of cancer management. It is the holy grail of a universal test with a high sensitivity and specificity for the detection of early cancer."

Dr. Gurdeep Singh Sethi, MD

CO-FOUNDER & DIRECTOR
Medidect™ India - A Unit of Millennium Oncology India Private Limited